课题基金 / 基金详情

Immune/Glial Mediation of Exaggerated Pain States

Immune/Glial Mediation of Exaggerated Pain States
夸大疼痛状态的免疫/神经胶质调节
批准号:
7071171
负责人:
LINDA WATKINS
金额:
$12.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-01 至 2008-05-31

项目摘要

项目成果

LINDA WATKINS的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): The PI's preclinical research program seeks to understand how activation of peripheral immune cells and central nervous system microglia and astrocytes triggers a cascade of events leading to neuronal activation and pathological pain states. This current research focus is directly relevant to her long-term goals of understanding (a) immune-neural interactions and (b) endogenous pain modulation systems. The proposed project is a request for a K02 award for the PI to develop skills now required by new results in programmatic investigations of pathological pain states. The 2 animal models employed induce clinically relevant exaggerated pain states by: (a) peri-spinal administration of HIV-1 gp 120 and (b) sciatic inflammatory neuropathy. Extensive evidence indicates that peripheral immune cells and spinal immune-like glial cells play critical roles in the creation and maintenance of exaggerated pain phenomena. Of the substances released by these cells upon activation, the strongest evidence to date points to the proinflammatory cytokines tumor necrosis factor, interleukin-1, and interleukin-6. These signaling molecules are key spinal mediators of pathological pain induced by both peri-spinal gp120 and sciatic inflammatory neuropathy. Their release from peri-sciatic immune cells is also correlated with the induction and intensity of sciatic inflammatory neuropathy. The two parent R01 grants are aimed at clarifying the immune/glial mechanisms underlying these pain models using immunological, anatomical, molecular, pharmacological, and behavioral approaches. The PI seeks to gain further training in molecular biology techniques (RNase Protection Assays, in situ hybridization, and adenoviral vectors for gene therapy), to enroll in responsible conduct of research coursework, and to continue her education through project-relevant coursework and research forums. Additionally, the released time will foster further professional growth by yielding coherent blocks of time for concentrating on research and review projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enduring enhancement of neuropathic pain by early post-trauma morphine
  • 批准号:
    9906887
  • 项目类别:
  • 资助金额:
    $53.04万
  • 财政年份:
    2018
  • 负责人:
    LINDA WATKINS
  • 依托单位:
Enduring enhancement of neuropathic pain by early post-trauma morphine
  • 批准号:
    10393512
  • 项目类别:
  • 资助金额:
    $53.04万
  • 财政年份:
    2018
  • 负责人:
    LINDA WATKINS
  • 依托单位:
Targeting neuropathic pain prevention: Modulating the neuroimmunology of peripheral nerve injury
  • 批准号:
    10062833
  • 项目类别:
  • 资助金额:
    $34.65万
  • 财政年份:
    2016
  • 负责人:
    LINDA WATKINS
  • 依托单位: